Business
Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024
NEWPORT BEACH, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC., (NASDAQ: ELAB) a pioneering force in medical aesthetics, is excited to announce
About this update from Pmgc Holdings Inc.
[{"type":"text","content":"NEWPORT BEACH, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC., (NASDAQ: ELAB) a pioneering force in medical aesthetics, is excited to announce Elevai Skincare’s participation in The Aesthetic Show, taking place on June 27-30, 2024 at the Wynn Las Vegas. The company will be showcasing its latest advancements at Booth #511 and unveiling the next generation of its groundbreaking stem cell exosome products. Jordan R. Plews, PhD, the CEO and Co-Founder of Elevai Skincare, will lead a highly anticipated presentation to introduce an innovative new product line. Joining Dr. Plews will be distinguished guest speaker Keshav Singh, PhD, a renowned scientist and inventor of one of the key active ingredients used in Elevai's new products. Event Details: Date: June 28, 2024Location: The Aesthetic Show, Las VegasBooth Number: 511Presentation Time: 3:30 PM About Jordan R. Plews, PhD: Dr. Jordan R. Plews is the Co-founder and CEO of Elevai Skincare. He completed his postdoctoral and business school training at Stanford University and holds degrees in Biochemical Engineering & Bioprocess Development, and Stem Cell Research & Molecular Biology from the UK. His research has been widely published in respected journals, including Nature Methods and the Journal of Cellular and Molecular Medicine. Dr. Plews has a distinguished career in stem cells and regenerative medicine, focusing on stem cell-based solutions for injury and degenerative diseases, before pivoting into aesthetics. About Keshav Singh, PhD: Dr. Singh is one of the world’s top five mitochondrial scientists, with time spent at Harvard, Johns Hopkins, Roswell Park Cancer Institute, and now Harbert Professor of Genetics and Director of the Cancer Genetics Program at UAB. He Co-Founded Yuva Biosciences, a regenerative medicine company that is developing the next generation of therapeutics to target aging and related illnesses through ground-breaking mitochondrial science Dr. Keshav also founded the journal Mitochondrion and the Mitochondria Research and Medicine Society, and has authored over 100 publications and 3 books. About Elevai Labs, Inc. Elevai Labs Inc. (NASDAQ: ELAB) specializes in medical aesthetics and biopharmaceutical drug development, focusing on innovations for skin aesthetics and treatments tied to obesity and metabolic health. Driven by a commitment to scientifi...